Skip to main content

Table 1 Anthropometirc measures of obese patients with NT, pre-HT and HT and their plasma metabolic parameters (vs their control group)

From: Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation

  Control-patients (N = 30) Obese patients
NT (N = 20) Pre-HT (N = 20) HT (N = 20)
Age (years) 14.5 ± 1.5 13.8 ± 0.9 14.7 ± 1.6 15.1 ± 1.1
Gender (M/F) 18/12 9/11 9/11 9/11
Diastolic BP (mmHg) 72. 5 ± 5.2 80.3 ± 2.1* 83.1 ± 2.5* 87.3 ± 2.6*, # a
Systolic BP (mmHg) 114 ± 6.1 117.5 ± 3.4 128.1 ± 3.9*, # 147 ± 6.5*, #, a
BMI 21.2 ± 1.2 32.9 ± 0.5* 32.2 ± 0.7* 33.6 ± 0.6*
Glucose (mg/dl) 78.2 ± 4.7 105.4 ± 3.3* 113.6 ± 1.8*, # 125.6 ± 5.3*,#, a
Insulin (µIU/ml) 5.5 ± 0.7 8.5 ± 0.4* 10.5 ± 1.5*, # 13.5 ± 0.7*, #, a
HOMA-index 1.1 ± 0.1 2.2 ± 0.03* 2.9 ± 0.06* 4.1 ± 0.09*, #, a
TG (mg/dl) 75.8 ± 10.4 198.7 ± 19.7* 206.5 ± 28.9* 215.9 ± 22.5*
TC (mg/dl) 132.1 ± 7.2 289.2 ± 16.7* 299.2 ± 30.7* 312.5 ± 21*, #
LDL-C (mg/dl) 77.2 ± 4.7 199.6 ± 12.8* 208. 5 ± 23.9* 218.9 ± 13.7*, #
HDL-C (mg/dl) 39.73 ± 3.5 49.75 ± 3.8* 49.46 ± 4.1* 50.53 ± 3.8*
Metabolic syndrome No No Yes Yes
  1. Values are mean ± SD for control healthy, obese normotensive, prehypertensive and hypertensive patients groups
  2. Values (*) is significantly different from control group; (#) significantly different from normotensive obese patients, (a) significantly different from prehypertensive obese patients
  3. Values are statistically significant at P < 0.05 using one way ANOVA with LSD as post hoc test. (SPSS program)